Advances in Health and Disease. Volume 61

$250.00

Lowell T. Duncan (Editor)

Series: Advances in Health and Disease
BISAC: MED000000

This book is a volume of eight collected chapters on advances in the sciences of health and disease. Chapter One examines the properties of regulatory peptides and their mechanisms of effect on integrative brain activity. Chapter Two reviews the role of inflammatory cytokines in the pathogenesis of rheumatoid arthritis and novel therapeutic targets. Chapter Three provides insight into Tnbs induced ulcerative colitis through the animal model, giving a wide ranging overview of the etiology, pathogenesis, clinical course and pathological features. Chapter Four is a broad overview of issues related to antimicrobial drugs. Chapter Five looks at alternative pharmaceutical options that are, eponymously, “better than Xanax.” Chapters Six and Seven are overviews of overweightness and obesity amongst Saudi and Bahraini adolescents, respectively. Finally, Chapter Eight is a review of muscarinic cholinergic receptor antagonism as a potential method of treating major depressive disorder.

Table of Contents

Preface

Chapter 1. Regulatory Peptides: The Mechanisms of Effects on Integrative Brain Activity
Liudmila A. Severyanova¹, MD, Dmitry V. Plotnikov², MD, and Ksenia D. Plotnikova³
¹Department of Pathophysiology, Kursk State Medical University, Kursk, Russia
²Department of Psychiatry, Kursk State Medical University, Kursk, Russia
³Pain Clinic, Krasnodar, Russia

Chapter 2. Role of Inflammatory Cytokines in the Pathogenesis of Rheumatoid Arthritis and Novel Therapeutic Targets
Deepa Mandlik and Satish Mandlik
Department of Pharmacology, Bharati Vidyapeeth (Deemed to be University), Poona College of Pharmacy, Erandwane, Pune, Maharashtra, India

Chapter 3. An Insight into TNBS Induced Ulcerative Colitis Through the Animal Model: Etiology, Pathogenesis, Clinical Course and Pathological Features
Vrushali R. Hambardikar, Satish S. Mandlik and Deepa S. Mandlik
Bharati Vidyapeeth (Deemed to be University), Poona College of Pharmacy, Erandwane, Pune, Maharashtra, India

Chapter 4. Antimicrobial Drug-Related Problems
Linh V. Pham¹, Suol T. Pham², Vu T. Nguyen², Thao H. Nguyen³, Katja Taxis⁴ and Thang Nguyen²
¹Hong Bang International University, Ho Chi Minh City, Vietnam
²Department of Pharmacology and Clinical Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam
³Department of Clinical Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam
⁴Unit of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands

Chapter 5. Better than Xanax
Jeffrey M. Witkin¹,³,⁴, Hana Shafique², Arnold Lippa¹, Kamal P. Pandey⁴, Jodi L. Smith³, James M. Cook¹,⁴ and Rok Cerne¹,³,⁵,⁶
¹RespireRx Pharmaceuticals Inc, Glen Rock, NJ, USA
²Duke University School of Medicine, Durham, NC, USA
³Laboratory of Antiepileptic Drug Discovery, Ascension St. Vincent, Indianapolis, IN USA
⁴Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
⁵Department of Anatomy and Cell Biology, Indiana University/Purdue University, Indianapolis, IN, USA
⁶Faculty of Medicine, University of Ljubljana, Zaloška cesta 4, Ljubljana, Slovenia

Chapter 6. The Prevalence of Overweightness and Obesity among Adolescents in the Kingdom of Saudi Arabia
Alexander Woodman, Ph.D.
School of Health Sciences, University of Salford, Manchester, England

Chapter 7. Prevalence and Key Determinants of Overweightness and Obesity among Bahraini Adolescents
Alexander Woodman, Ph.D.
School of Health Sciences, University of Salford, Manchester, England

Chapter 8. Muscarinic Cholinergic Receptor Antagonism: One Doorway to Rapid Relief from Major Depressive Disorder
Jeffrey M. Witkin¹, Anna E. Martin² and Jodi L. Smith¹
¹Laboratory of Antiepileptic Drug Discovery, Ascension St. Vincent, Indianapolis, IN, USA
²Indiana University School of Medicine, Fort Wayne, IN, USA

Index